Eosinophil β1 integrin activation state correlates with asthma activity in a blind study of inhaled corticosteroid withdrawal - 20/08/11
Doi : 10.1016/j.jaci.2006.02.032
Mats W. Johansson, PhD a, Steven R. Barthel, PhD a, b, Cheri A. Swenson, BS a, Michael D. Evans, MS c, Nizar N. Jarjour, MD a, Deane F. Mosher, MD a, b, William W. Busse, MD a
a From the Departments of Medicine
b Biomolecular Chemistry
c Biostatistics and Medical Informatics, University of Wisconsin, Madison
Le texte complet de cet article est disponible en PDF.
| Supported by Specialized Center of Research grant HL56396 and General Clinical Research Center grant M01 RR03186 from the National Institutes of Health. Disclosure of potential conflict of interest: N. Jarjour has consultant arrangements with Asthmatax and has received grants from GlaxoSmithKline, Dynavax, and Roche. The rest of the authors have declared that they have no conflict of interest. |
© 2006
American Academy of Allergy, Asthma and Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 117 - N° 6
P. 1502-1504 - juin 2006 Retour au numéro
Article précédent
- Obesity and airway inflammation in asthma
- Renata Barros, André Moreira, João Fonseca, Pedro Moreira, Lia Fernandes, José Ferraz de Oliveira, Luís Delgado, M. Graça Castel-Branco
- Two cases of anaphylaxis caused by perilla seed
- Yi Yeong Jeong, Hae-Sim Park, Jeong Hee Choi, Sang-Heon Kim, Kyung-Up Min
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?